Mia's Feed
Medical News & Research

New Insights into the Intersection of HIV and Alzheimer's Disease at the Molecular Level

New Insights into the Intersection of HIV and Alzheimer's Disease at the Molecular Level

Share this article

A groundbreaking study uncovers how a protein fragment linked to Alzheimer's disrupts HIV's assembly in brain cells, revealing new insights into viral reservoirs and neurodegeneration.

2 min read

Recent research from Northwestern Medicine has uncovered a surprising connection between HIV-1 and proteins associated with Alzheimer's disease. Published in the Proceedings of the National Academy of Sciences, the study reveals how a fragment of amyloid precursor protein (APP), known as C99, interferes with HIV-1's ability to assemble and release new viral particles within brain cells, specifically macrophages and microglia. These immune cells act as reservoirs for the virus in the brain, where infection can lead to neurocognitive disorders.

The research highlights that C99 blocks HIV-1 from accessing multivesicular bodies (MVBs), the cellular compartments where the virus typically assembles, thereby hindering its replication. This interference occurs because C99 and HIV-1 Gag proteins compete for vital host proteins like TSG101 and VPS4A, which are crucial for vesicular sorting processes. Interestingly, depletion of TSG101 impairs HIV-1 replication unless C99 is also reduced, implying a direct competition for these cellular factors.

The findings suggest a complex interplay: while processing through MVBs is necessary for HIV replication, it also leads to the production of neurotoxic amyloid peptides linked to Alzheimer’s disease. This creates a conflict within infected brain cells, balancing viral propagation and neurodegeneration.

Furthermore, the virus may promote the breakdown of C99 to evade its inhibitory effects, but this process inadvertently increases the production of amyloidogenic toxins, which damage brain cells. The team is now investigating how these mechanisms function in neurons, using stem cell-derived models to better understand the implications for neurodegenerative conditions.

Overall, this research sheds new light on the molecular crosstalk between HIV infection and neurodegeneration, potentially opening new avenues for treatments that address both viral reservoirs and neurodegenerative pathology. It emphasizes the importance of understanding vesicular sorting pathways in brain health and disease.

Source: https://medicalxpress.com/news/2025-09-hiv-alzheimer-pathways-collide-protein.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Scientists Discover Unique Blood Type in Guadeloupe Woman

A rare blood type called "Gwada negative" has been discovered in a woman from Guadeloupe, marking a milestone in blood group research and opening new avenues for personalized medical care.

First-Time Mothers Face Severely Disrupted Sleep in Early Postpartum Period

New mothers experience severe sleep disruption during the first weeks after childbirth, averaging just 4.4 hours of sleep with persistent fragmentation for months, impacting postpartum recovery and mental health.

Breakthrough Immunotherapy Enhances Outcomes in High-Risk Blood Cancer Patients

A new clinical trial reveals that adding glofitamab immunotherapy to standard treatments dramatically improves outcomes in high-risk blood cancer patients, showing high response and survival rates.

Comparable Survival Outcomes for Simple and Radical Hysterectomy in Low-Risk Cervical Cancer

A large study finds that simple hysterectomy offers similar long-term survival to more extensive procedures in women with low-risk early-stage cervical cancer, supporting less invasive options.